Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00186264|
Recruitment Status : Unknown
Verified December 2007 by Stanford University.
Recruitment status was: Active, not recruiting
First Posted : September 16, 2005
Last Update Posted : December 20, 2007
|Condition or disease||Intervention/treatment||Phase|
|Depressive Disorder, Major||Drug: venlafaxine XR Drug: hydrocortisone||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||20 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?|
|Study Start Date :||August 2002|
|Study Completion Date :||April 2006|
- To determine if treatment of major depression with hydrocortisone concurrent with starting venlafaxine XR speeds onset of antidepressant action.
- To determine if hydrocortisone pre-treatment augments venlafaxine XR response.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00186264
|United States, California|
|Stanford University School of Medicine|
|Stanford, California, United States, 94305|
|Principal Investigator:||Charles DeBattista||Stanford University|